Johnson & Johnson JNJ today announced that it has accepted the binding offer from The Carlyle
Group, which was received and announced on January 16, 2014, to acquire its
Ortho-Clinical Diagnostics business for approximately $4 Billion, subject to
customary adjustments. This acceptance was made after consultation with the
relevant works councils and trade unions. The transaction is expected to close
toward the middle of the year, upon satisfaction of customary closing
conditions.
Johnson & Johnson will discuss any updates during its scheduled quarterly
earnings call on April 15, 2014.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in